International Day for Fighting Infection

Published: 16-Mar-2015

24 April 2015

Event

Copenhagen, Denmark


The European Society for Clinical Microbiology and Infectious Diseases (ESCMID) has been joined by the World Health Organization (WHO) to launch the 7th annual International Day for Fighting Infection. This year’s event sees the European society exploring vaccines as a possible solution in the global, cross-border fight against antimicrobial resistance.

The event is free for anyone to attend. The overall mission of the day is to increase international collaboration and to highlight cutting-edge methods in the battle against infectious disease. The WHO will be providing an update from its European office across Ebola, Extensively drug-resistant tuberculosis and polio, while ESCMID will explore how we can start harnessing the potential of vaccines in the intensifying battle against antimicrobial resistance.

Organiser: European Society for Clinical Microbiology and Infectious Diseases (ESCMID)

Trending Articles

  1. Cleanroom Conference UK 22–23 May 2024 | Exhibition | Birmingham, UK
  2. Lounges 23-25 April 2024 | Conference | Messe Karlsruhe, Germany
  3. Interphex 16-18 April 2024 | Conference and Exhibition | New York, US
  4. Making Pharmaceuticals 23–24 April 2024 | Exhibition | Coventry, UK
  5. CPhI Middle East 10–12 December 2024 | Conference | Riyadh, Saudi Arabia

You may also like

Regulatory

WHO proposes central registry on human genome editing research

On the heels of the Chinese CRISPR scandal, stakeholders in the genome editing industry will be consulted to create standards for future research
Research & Development

Measles vaccine increases child survival beyond measles protection

New study shows all-cause mortality is significantly lower when a child's most recent immunisation is a measles vaccine
Regulatory

Annex 1 harmonisation moves a step closer

Revision to Annex 1 on the manufacturing of sterile medicinal products of the PIC/S – EU GMP Guide goes out for joint stakeholder consultation
You need to be a subscriber to read this article.
Click here to find out more.
Pharmaceutical

Zika outbreak gives rise to global fears

Zika may not be a new virus but its newly confirmed ability to cause foetal brain abnormalities makes the search for a treatment or a vaccine a high priority. Dr Sarah Houlton looks at the latest initiatives
Research & Development

Antimicrobial drug pipelines presented at ECCMID

Novel antibiotics are under development to overcome antibacterial resistance
Ingredients

ESCMID’s EUCAST defining resistance in future antimicrobial agents

EUCAST’s unheralded but vital work is helping to ensure responsible use by defining common standards for antimicrobial resistance globally
Drug Delivery

World's first child-friendly TB medicines in correct doses

The new fixed-dose formulations for children will offer hope for the 400 children who needlessly die of TB each day
Subscribe now